PROGRAM LEADERS Dr Malcolm Brenner is the Director of the Center for Cell and Gene Therapy and serves as Leader of the Cancer Center Cell and Gene Therapy (CCGT) program. He is an internationally known investigator in the field of cell and gene therapy, who has served as President of both the American Society of Gene Therapy and the International Society for Cell Therapy. He is currently an Associate Editor of Blood and the incoming Editor in Chief of Molecular Therapy. He has made major contributions to the field, including gene-marking studies which provided important information about the source of relapse post transplant and the. biology of hemopoietic recovery. He has developed cancer vaccine studies using genetically modified tumor cells and used T cell subpopulations to improve immune reconstitution post transplant. He is extensively published in these areas. Dr Brenner directs the NHLBI Specialized Center of Research in Cell Therapy, and has a significant track record in effectively mentoring trainees and junior faculty members. Thus, Dr Brenner brings exceptional leadership and administrative skills to the program. Dr Helen Heslop, who is the co-Leader of the program, was a Doris Duke distinguished clinical scientist and is PI on several peer-reviewed clinical research programs and projects, including an NCI-funded program project grant (Enhancing T-Cell Therapy of Cancer, CA 94237), a SPORE in Lymphoma, and a Leukemia and Lymphoma Society Specialized Center of Research (SCOR) award (Immunotherapy of Lymphoma). In her clinical role, Dr Heslop currently directs the adult stem cell transplant program in the CAGT. She has extensive experience in mentoring both clinical and laboratory trainees, and is the principal investigator on the NHLBl funded training grant in Cell and Gene Therapy. She is a co-editor of Bone Marrow Transplantation and an Associate Editor of Biology of Blood and Marrow Transplantation. She is the immediate Past President of the American Society for Blood and Marrow Transplantation;Vice President of the Foundation for Accreditation of Cell Therapy;and a member of the Board of Directors of the American Society of Gene Therapy. She is also a member of the NCI Lymphoma Steering Committee. As will be apparent from this list, she has exceptional administrative skills.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
United States
Zip Code
Gargett, Tessa; Yu, Wenbo; Dotti, Gianpietro et al. (2016) GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade. Mol Ther 24:1135-49
Giudice, Jimena; Loehr, James A; Rodney, George G et al. (2016) Alternative Splicing of Four Trafficking Genes Regulates Myofiber Structure and Skeletal Muscle Physiology. Cell Rep 17:1923-1933
Kundu, S T; Byers, L A; Peng, D H et al. (2016) The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene 35:173-86
Treviño, Lindsey S; Bolt, Michael J; Grimm, Sandra L et al. (2016) Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Mol Endocrinol 30:158-72
Oliver, Nora T; Hartman, Christine M; Kramer, Jennifer R et al. (2016) Statin drugs decrease progression to cirrhosis in HIV/HCV co-infected individuals. AIDS :
Aisiku, Imo P; Yamal, Jose-Miguel; Doshi, Pratik et al. (2016) Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Crit Care 20:288
Li, Yiting; Nakka, Manjula; Kelly, Aaron J et al. (2016) p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma. Cancer Res 76:4002-11
Ren, Yi A; Liu, Zhilin; Mullany, Lisa K et al. (2016) Growth Arrest Specific-1 (GAS1) Is a C/EBP Target Gene That Functions in Ovulation and Corpus Luteum Formation in Mice. Biol Reprod 94:44
Pankowicz, Francis P; Barzi, Mercedes; Legras, Xavier et al. (2016) Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nat Commun 7:12642
Ramos, Carlos A; Savoldo, Barbara; Torrano, Vicky et al. (2016) Clinical responses with T lymphocytes targeting malignancy-associated κ light chains. J Clin Invest 126:2588-96

Showing the most recent 10 out of 683 publications